Literature DB >> 22607823

Statins for all by the age of 50 years?

Shah Ebrahim1, Juan P Casas.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22607823     DOI： 10.1016/S0140-6736(12)60694-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  On the hypothetical universal use of statins in primary prevention: an observational analysis on low-risk patients and economic consequences of a potential wide prescription rate.

Authors:  Alejandro Macchia; Javier Mariani; Marilena Romero; Fabio Robusto; Vito Lepore; Antonio Dettorre; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2015-02-11       Impact factor: 2.953

2.  Statins for primary prevention: identifying low-risk individuals.

Authors:  Yu-li Huang; Yi Huang; Yan-xian Wu
Journal:  Nat Rev Cardiol       Date:  2013-07-23       Impact factor: 32.419

Review 3.  Almost everyone over 50 should be put on a statin to reduce the risk of cardiovascular disease: A protagonist view.

Authors:  Pratik Sandesara; Douglas B Bogart
Journal:  Mo Med       Date:  2013 Jul-Aug

Review 4.  How do we improve patient compliance and adherence to long-term statin therapy?

Authors:  Patricia Maningat; Bruce R Gordon; Jan L Breslow
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

Review 5.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

6.  Ciprofloxacin and statin interaction: a cautionary tale of rhabdomyolysis.

Authors:  Fraser Charles Goldie; Amy Brogan; James Graham Boyle
Journal:  BMJ Case Rep       Date:  2016-07-28

7.  Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin.

Authors:  Abdulrahman K Al-Asmari; Zabih Ullah; Fahad Al-Sabaan; Mohammad Tariq; Ahmed Al-Eid; Saud F Al-Omani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-04-18       Impact factor: 2.441

8.  High-potency statins and acute kidney injury-associated hospitalizations.

Authors:  Colin R Lenihan; Richard A Lafayette
Journal:  Am J Kidney Dis       Date:  2013-08-22       Impact factor: 8.860

9.  Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia.

Authors:  Eunmi Ahn; Dong Wook Shin; Hyung-kook Yang; Jae Moon Yun; So Hyun Chun; Beomseok Suh; Hyejin Lee; Ki Young Son; BeLong Cho
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

Review 10.  Area-level deprivation and overall and cause-specific mortality: 12 years' observation on British women and systematic review of prospective studies.

Authors:  Maria T Sánchez-Santos; Marco Mesa-Frias; Minkyoung Choi; Eveline Nüesch; Angel Asunsolo-Del Barco; Antoinette Amuzu; George Davey Smith; Shah Ebrahim; David Prieto-Merino; Juan P Casas
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.